Evommune, Inc. financial statements
Evommune, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 13M | 10-K |
| Net income | −USD 68.87M | 10-K |
| Cash and equivalents | USD 44.06M | 10-Q |
| Total debt | USD 1.71M | EODHD |